Skip to content

Enhancing Resilience in Senior Community Residents

Enhancing Resilience in Senior Living Community Residents: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05438134
Enrollment
288
Registered
2022-06-29
Start date
2022-06-24
Completion date
2023-04-05
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Stress, Psychological

Keywords

Resiliency, Flourishing, Coping Skills, Stress Reduction, Healthy Aging

Brief summary

This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigators hypothesize that participants in the SMART-3RP group will report greater increases in resilience and flourishing relative to participants in the control group.

Detailed description

This randomized control trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP) to improve resilience and flourishing among older adults residing in continuing care retirement communities relative to a wait-list control group. At enrollment, participants will be randomly assigned to the intervention group or the control group using computer generated 1:1 blocked randomization stratified by community site. The intervention group will receive the SMART-3RP program immediately upon enrollment; the wait-list control group will be invited to receive the SMART-3RP program after the final survey time point. An estimate of 360 participants will be recruited from up to nine geographically diverse Erickson Senior Living communities.

Interventions

Nine 1.5 hour group sessions focusing on developing: 1. An understanding of stress physiology and the physiology of the relaxation response; 2. A regular practice of eliciting the relaxation response; and 3. Cognitive behavioral and positive psychology/resilience skills. Participants receive a copy of the SMART-3RP session manual and audio recorded guided meditations for independent relaxation practice. Participants are encouraged to practice eliciting the relaxation response daily throughout the study, using the audio recordings or other mind body techniques. Participants will use a practice log to track their practice.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Resident of an Erickson Senior Living community * Currently residing in an Erickson Senior Living apartment home * Sufficient English language skills to participate in study procedures

Exclusion criteria

* Unable or unwilling to provide informed consent * Unable or unwilling to participate in in-person group sessions

Design outcomes

Primary

MeasureTime frameDescription
Resilience: Current Experiences Scale (CES)Up to 12 weeksWe will investigate longitudinal differences in resilience between study groups (CES score range 0-115), with higher scores indicating greater resilience.
Flourishing: Flourishing Measure (FM)Up to 12 weeksWe will investigate longitudinal differences in flourishing between study groups (FM score range 0-10), with higher scores indicating greater flourishing.

Secondary

MeasureTime frameDescription
Physical symptoms: Condensed Memorial Symptom Assessment Scale (CMSAS)Up to 12 weeksWe will investigate longitudinal differences in physical symptom burden between study groups (CMSAS score range 0-48, with higher scores indicating greater symptom burden.
Coping self-efficacy: Measure of Current Status - Part A (MOCS-A)Up to 12 weeksWe will investigate longitudinal differences in coping self-efficacy between study groups (MOCS-A score range 0-52), with higher scores indicating greater self-efficacy.
Psychological distress: Patient Health Questionnaire 4 (PHQ4)Up to 12 weeksWe will investigate longitudinal differences in psychological distress between study groups (PHQ4 score range 0-12), with higher scores indicating greater distress.
Positive affect: Positive and Negative Affect Schedule - Positive Subscale (PANAS-POS)Up to 12 weeksWe will investigate longitudinal differences in positive affect between study groups (PANAS-POS range 10-50), with higher scores indicating greater positive affect.
Community well-being: Community Well Being Survey (CWB)Up to 12 weeksWe will investigate longitudinal differences in community well-being between study groups (CWB range 0-10), with higher scores indicating greater community well-being.
Social isolation: Patient-Reported Outcomes Measurement Information System - Social Isolation (PROMIS-SI)Up to 12 weeksWe will investigate longitudinal differences in social isolation between study groups (PROMIS-SI score range 4-20), with higher scores indicating greater isolation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026